<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="the Major Article by Chu et al on pages 1400â€&quot;9.)" exact="Coronavirus disease 2019" post="(COVID-19), a respiratory illness caused by a novel coronavirus,"/>
 <result pre="the much more limited SARS outbreak of 2002â€&quot;2003, and to" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), the etiologic agent for MERS. SARS-CoV-2 differs"/>
 <result pre="IFN production likely hampers the early innate immune response to" exact="SARS-CoV-2 infection." post="The authors obtained human lung tissue samples from 6"/>
 <result pre="for SARS-CoV-2 than SARS-CoV. The higher viral levels associated with" exact="SARS-CoV-2 infection" post="may reflect an even more striking observation from this"/>
 <result pre="In previous work from Professor Yuenâ€™s group, neither MERS-CoV nor" exact="SARS-CoV infection" post="induced significant expression of type I IFNs in human"/>
 <result pre="are as yet no data with respect to treatment of" exact="SARS-CoV-2 infection" post="with IFN-Î»; however, there are relevant data concerning SARS-CoV"/>
 <result pre="hepatitis, where pegylated IFN-Î»1 has been tested so far, and" exact="SARS-CoV-2 infection" post="is that patients with severe COVID-19 have a high"/>
 <result pre="and, ideally, should be first studied in patients with early" exact="SARS-CoV-2 infection" post="or as prophylaxis. Possible trials of pegylated IFN-Î»1 for"/>
 <result pre="J Virol2013; 87:6604â€&quot;14.23552422 13.ZhouJ, ChuH, LiC, et al.Active replication of" exact="Middle East respiratory syndrome" post="coronavirus and aberrant induction of inflammatory cytokines and chemokines"/>
</results>
